415 related articles for article (PubMed ID: 12025827)
1. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
Thase ME; Rush AJ; Manber R; Kornstein SG; Klein DN; Markowitz JC; Ninan PT; Friedman ES; Dunner DL; Schatzberg AF; Borian FE; Trivedi MH; Keller MB
J Clin Psychiatry; 2002 Jun; 63(6):493-500. PubMed ID: 12088160
[TBL] [Abstract][Full Text] [Related]
3. Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
Zajecka J; Dunner DL; Gelenberg AJ; Hirschfeld RM; Kornstein SG; Ninan PT; Rush AJ; Thase ME; Trivedi MH; Arnow BA; Borian FE; Manber R; Keller MB
J Clin Psychiatry; 2002 Aug; 63(8):709-16. PubMed ID: 12197452
[TBL] [Abstract][Full Text] [Related]
4. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
Hirschfeld RM; Dunner DL; Keitner G; Klein DN; Koran LM; Kornstein SG; Markowitz JC; Miller I; Nemeroff CB; Ninan PT; Rush AJ; Schatzberg AF; Thase ME; Trivedi MH; Borian FE; Crits-Christoph P; Keller MB
Biol Psychiatry; 2002 Jan; 51(2):123-33. PubMed ID: 11822991
[TBL] [Abstract][Full Text] [Related]
5. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.
Kocsis JH; Leon AC; Markowitz JC; Manber R; Arnow B; Klein DN; Thase ME
J Clin Psychiatry; 2009 Mar; 70(3):354-61. PubMed ID: 19192474
[TBL] [Abstract][Full Text] [Related]
6. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Manber R; Rush AJ; Thase ME; Amow B; Klein D; Trivedi MH; Korenstein SG; Markowitz JC; Dunner DL; Munsaka M; Borian FE; Martin ; Keller B
Sleep; 2003 Mar; 26(2):130-6. PubMed ID: 12683470
[TBL] [Abstract][Full Text] [Related]
7. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF; Rush AJ; Arnow BA; Banks PL; Blalock JA; Borian FE; Howland R; Klein DN; Kocsis JH; Kornstein SG; Manber R; Markowitz JC; Miller I; Ninan PT; Rothbaum BO; Thase ME; Trivedi MH; Keller MB
Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
[TBL] [Abstract][Full Text] [Related]
8. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Rush AJ; Trivedi MH; Carmody TJ; Ibrahim HM; Markowitz JC; Keitner GI; Kornstein SG; Arnow B; Klein DN; Manber R; Dunner DL; Gelenberg AJ; Kocsis JH; Nemeroff CB; Fawcett J; Thase ME; Russell JM; Jody DN; Borian FE; Keller MB
Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
[TBL] [Abstract][Full Text] [Related]
9. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Kocsis JH; Rush AJ; Markowitz JC; Borian FE; Dunner DL; Koran LM; Klein DN; Trivedi MH; Arnow B; Keitner G; Kornstein SG; Keller MB
Psychopharmacol Bull; 2003; 37(4):73-87. PubMed ID: 15131518
[TBL] [Abstract][Full Text] [Related]
10. Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
Manber R; Arnow B; Blasey C; Vivian D; McCullough JP; Blalock JA; Klein DN; Markowitz JC; Riso LP; Rothbaum B; Rush AJ; Thase ME; Keller MB
Psychol Med; 2003 May; 33(4):693-702. PubMed ID: 12785471
[TBL] [Abstract][Full Text] [Related]
11. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
12. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Zajecka JM
J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
[TBL] [Abstract][Full Text] [Related]
14. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Keller MB; McCullough JP; Klein DN; Arnow B; Dunner DL; Gelenberg AJ; Markowitz JC; Nemeroff CB; Russell JM; Thase ME; Trivedi MH; Zajecka J
N Engl J Med; 2000 May; 342(20):1462-70. PubMed ID: 10816183
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
[TBL] [Abstract][Full Text] [Related]
16. Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression.
Denton WH; Carmody TJ; Rush AJ; Thase ME; Trivedi MH; Arnow BA; Klein DN; Keller MB
Psychol Med; 2010 Mar; 40(3):415-24. PubMed ID: 19607755
[TBL] [Abstract][Full Text] [Related]
17. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
18. Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients.
Assmann N; Schramm E; Kriston L; Hautzinger M; Härter M; Schweiger U; Klein JP
Depress Anxiety; 2018 Oct; 35(10):1001-1008. PubMed ID: 30199128
[TBL] [Abstract][Full Text] [Related]
19. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
Saiz-Ruiz J; Ibañez A; Díaz-Marsá M; Arias F; Carrasco JL; Huertas D; Martín-Carrasco M; Moreno I; Rico-Villademoros F
CNS Drugs; 2002; 16(9):635-43. PubMed ID: 12153334
[TBL] [Abstract][Full Text] [Related]
20. Detecting critical decision points in psychotherapy and psychotherapy + medication for chronic depression.
Steidtmann D; Manber R; Blasey C; Markowitz JC; Klein DN; Rothbaum BO; Thase ME; Kocsis JH; Arnow BA
J Consult Clin Psychol; 2013 Oct; 81(5):783-92. PubMed ID: 23750462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
